Graeme Newing

Thursday 23 Apr I had been hoping with heart in my mouth that the stock would break upside from that consolidation pattern that had contained the stock for the past few days. Today it did just that! It finished at 26.5¢, up 8.5¢ or 47% on the day, making it up over 5 times my

Wednesday 15 April Yesterday I sold the position in PEH and bought into E88 and MBE. Shares of Pacific Environment Ltd (PEH) broke their short term uptrend line on Tuesday and under my trading system I had no choice but to sell. I achieved 10.5¢ which was a slight loss on my purchase price of 10.6¢

AZK rose another 4.5¢ to 19.0¢, so have trebled my money in less than a month. Not often I get one like this! Will have to watch it like a hawk now,and sell as soon as the very steep uptrend line is broken.

AKP fell through a short term uptrend line a couple of days ago and recovered a little yesterday. The decision to sell, however, is clouded by the fact that it has not yet breached an alternative short term uptrend line. I will give it the benefit of the doubt at this point.

Yesterday CAJ fell 7¢ to 98¢ and in doing so it breached a short term uptrend line. The longer term uptrend is still in place but I believe the short term momentum has been lost and that the shares could drift back to the 75-80¢ level. I made the decision last night to sell and I

Capitol Health provides diagnostic medical imaging services to radiology practices. Until recently it was entirely Victorian based but in March 2015 it expanded into NSW with the $64.6m purchase of Southern Radiology in Sydney. This followed hard on the heels of a similar $25m acquisition in Melbourne. These acquisitions together had achieved revenues of $47.4m and EBITDA of $10.5m

Sold the position in AMA today, at 54¢. The price has stalled in the last week or so but the chart has not broken down at this point. However I needed the money.

Aziana’s suspension was lifted today after an announcement that due diligence on Brinchip was successfully concluded and that the option to purchase has been exercised. So it was good news, not bad news as I had feared. The shares shot up to a new high of 14.5¢ so now I have trebled my money in a matter

ARU (Arafura Resources) 6.5¢ Smarttrans (SMA) 2.2¢ St Barbara (SBM) 27¢

Medical Developments International Ltd (ASX:MVP) is a small but well established and profitable biotech company. Its main product is Penthrox, a fast onset, non-opioid analgesic indicated for pain relief, self-administered via an inhaler by conscious patients with trauma and those requiring analgesia for surgical procedures. It is much superior to rival products such as Panadol 4 or

Alzheimer’s is the only one among the top ten causes of death in America that cannot be prevented, cured or even slowed. One in three elderly persons dies with Alzheimer’s or another dementia. Actinogen (ASX:ACW) is developing a novel treatment for Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI). Its drug Xanamem blocks production in the brain of

Here is my current portfolio of Chart Investments (chosen primarily for chart breakouts). I have reviewed some of them in the blog over the last couple of weeks and will tackle the others over time. Very few have been held more than a year, and the number of stocks sold so far this year is 44, twice as many

Pro Medicus (ASX:PME) is a profitable and fast growing software developer within the healthcare industry, providing radiology information systems and practice management software to radiologist practices and hospitals. It has operations in Australia, Europe and more recently in the USA. Its greatest growth potential is in the USA. With 100.3m shares outstanding, the current share price of $1.58

AZK has doubled to 10¢ since I bought them last week. Am holding for the moment.

Today I sold the position in MNY, half the position in IWG and with the proceeds bought into CVT. MNY was purchased in Sep and Oct 2014 at an average of $1.24 and by February 2015 it had advanced to $1.77. The subsequent pullback violated the uptrend line and under my rules I had to

I bought shares in Audio Pixels Ltd (ASX:AKP) at an average of $9.48 in November and December 2014. The shares are now $10.85, which with 25.7m shares issued gives it a market cap of $279m. Not a bad valuation for a company with no revenues! From its laboratory in Israel, Audio Pixels has developed digital technology for

I sold the position in API today, at $1.835. It was a good gain as I had bought them on 4 Sep last year at 71¢, purely on the charts. There is no sign of the momentum slowing, but I needed the money. Australian Pharmaceutical Industries Ltd (ASX:API) has a market cap of over $900m

I bought GER at 7.2c in November 2014. The shares are now 10¢ and with 197.6m shares on issue it capitalises the company at almost $20m. Greenearth Energy Ltd (ASX:GER) has suffered a cash deficit from operations of between $0.5m and $0.8m for each of the last four quarters and its cash position at 31 December 2014

I bought Altium (ASX:ALU) in September through October 2014 at an average price of $3.15 including brokerage. It is currently at $4.43 which gives it a market cap of $573m. At 31 December 2014 it had cash of US$59m and no borrowings. The company’s focus is on developing software design tools for engineers to create printed circuit boards

LER is another of my portfolio stocks. I bought it between November 2014 and March 2015 at an average of just under 19¢. With 113.4m shares, at the current price of 16¢ its market cap is just over $18m. Leaf’s claim to fame is its Glycell technology, enabling very cheap production of cellulose from waste biomass. It

A new investment of mine is Aziana (ASX: AZK) . I bought at 4.7¢ on Friday and it finished the day 4.3¢. With 204.2m shares on issue it had a market cap of $8.8m. Until last week it was a mineral exploration company operating in Madagascar but on 18 March it announced a HOA to buy BrainChip Inc.,